Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489885 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
A Phase 2 study, sponsored by InventisBio Co..
- Recruiting
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT07489885 is a Phase 2 study that is actively recruiting participants, run by InventisBio Co.. The registered enrollment target is 75 participants.
The verdict
NCT07489885, a Phase 2 study, is actively recruiting participants, sponsored by InventisBio Co..
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Interventions
- DRUG Placebo Tablets
- DRUG D-2570 Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-06-03 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07489885
The ClinicalTrials.gov registry entry for NCT07489885 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InventisBio Co., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Tablets is the first listed.
NCT07489885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07489885 about?
NCT07489885 is a clinical study titled "A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis". A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
What is the current status of trial NCT07489885?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2026-06-03. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07489885?
The interventions under investigation include: Placebo Tablets (DRUG), D-2570 Tablet (DRUG).
Who is sponsoring clinical trial NCT07489885?
This trial is sponsored by InventisBio Co., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.